236 related articles for article (PubMed ID: 9005348)
1. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
Schmauss M
Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
[TBL] [Abstract][Full Text] [Related]
2. Refractory depression treated with high doses of monoamine oxidase inhibitor.
Guze BH; Baxter LR; Rego J
J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
[TBL] [Abstract][Full Text] [Related]
3. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
4. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
5. Pindolol augmentation of tranylcypromine in psychotic depression.
Kraus RP
J Clin Psychopharmacol; 1997 Jun; 17(3):225-6. PubMed ID: 9169970
[No Abstract] [Full Text] [Related]
6. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
7. The role of monoamine oxidase inhibitors in depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
Radat F; Berlin I; Varoquaux O; Ferreri M; Puech A
Ann Med Psychol (Paris); 1996 Jun; 154(3):204-6. PubMed ID: 8766502
[No Abstract] [Full Text] [Related]
9. Drug combinations in the treatment of refractory depression: a review.
Stern SL; Mendels J
J Clin Psychiatry; 1981 Oct; 42(10):368-73. PubMed ID: 6116699
[TBL] [Abstract][Full Text] [Related]
10. Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases.
Quante A; Zeugmann S
J Clin Psychopharmacol; 2012 Aug; 32(4):572-4. PubMed ID: 22760351
[No Abstract] [Full Text] [Related]
11. [Practical considerations in initial treatment].
Allilaire JF
Encephale; 1995 Mar; 21 Spec No 2():23-9. PubMed ID: 7588174
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
[No Abstract] [Full Text] [Related]
13. High-dosage tranylcypromine in refractory depression.
Pearlman C
J Clin Psychiatry; 1987 Oct; 48(10):424-5. PubMed ID: 3667544
[No Abstract] [Full Text] [Related]
14. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.
Nolen WA; van den Broek WW; Birkenhäger TK
Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480
[No Abstract] [Full Text] [Related]
15. High dose tranylcypromine therapy for refractory depression.
Amsterdam JD; Berwish NJ
Pharmacopsychiatry; 1989 Jan; 22(1):21-5. PubMed ID: 2710808
[TBL] [Abstract][Full Text] [Related]
16. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
[No Abstract] [Full Text] [Related]
17. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
18. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
[No Abstract] [Full Text] [Related]
19. [Prognostic value of pharmaco-EEG in depression treated with moclobemide].
Wiśniewski G; Jakitowicz J; Nowicki Z; Pankiewicz P
Psychiatr Pol; 2002; 36(6 Suppl):93-8. PubMed ID: 12647427
[TBL] [Abstract][Full Text] [Related]
20. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
